@ARTICLE{
author={Pillai Rathi N,Fennell Dean A,Kovcin Vladimir N,Ciuleanu Tudor E,Ramlau Rodryg,Kowalski Dariusz,Schenker Michael,Yalcin Ilker,Teofilovici Florentina,Vukovic Vojo M,Ramalingam Suresh S},
year={2020},
title={Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={38},
number={6},
pages={613-+},
document_type={Article},
} 

@ARTICLE{
author={Pillai Rathi N,Fennell Dean,Kovcin Vladimir N,Ciuleanu Tudor E,Ramlau Rodryg,Kowalski Dariusz,Schenker Michael,Perin Branislav M,Yalcin Ilker,Teofilovici Florentina,Vukovic Vojo M,Ramalingam Suresh S},
year={2017},
title={Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={12},
number={1},
pages={S7-S8},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Zaric Bojan,Andric Zoran G,...,(broj koautora 22)},
year={2015},
title={A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)},
journal={ANNALS OF ONCOLOGY},
volume={26},
number={8},
pages={1741-1748},
document_type={Article},
} 

@ARTICLE{
author={Ramalingam Suresh S,Zaric Bojan,Ceric Timur,...,Samarzija Miroslav,...,Vukovic Vojislav M,(broj koautora 20)},
year={2014},
title={Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={32},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Zaric Bojan,...,Andric Zoran G,...,(broj koautora 26)},
year={2013},
title={Galaxy-1: Randomized Phase Ii Study of Docetaxel with Or Without Ganetespib in Advanced Lung Adenocarcinoma: Results in Biomarker Sub-Groups and All Adenocarcinoma Patients.},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={8},
number={},
pages={S139-S139},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Andric Zoran G,...,Zaric Bojan,...,Vukovic Vojislav M,...,(broj koautora 20)},
year={2013},
title={A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={18},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Andric Zoran G,...,Zaric Bojan,Ceric Timur,...,Vukovic Vojislav M,...,(broj koautora 20)},
year={2013},
title={A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Fennell DA,Goss GD,Andric Zoran G,Bondarenko Igor N,Zaric Bojan,Ceric Timur,Poddubskaya Elena,Teofilovici F,Guo W,Ramalingam Suresh S},
year={2013},
title={Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={},
pages={S801-S801},
document_type={Meeting Abstract},
}